$NYSE:CRL

Charles River Laboratories expands cell therapy facility

Trending News ☀️ Charles River Laboratories ($NYSE:CRL), a global provider of drug discovery, development and manufacturing services, has expanded its [...]

By GoodWhale|November 17, 2022|Categories: Diagnostics & Research|Tags: $NYSE:CRL, Diagnostics & Research, NYSE|0 Comments

Charles River Laboratories beats earnings estimates by $0.13 in Q3

Trending News 🌥️ CRL Intrinsic Stock Value – Charles River Laboratories ($NYSE:CRL) is a global provider of biologic and preclinical [...]

By GoodWhale|November 14, 2022|Categories: Diagnostics & Research|Tags: $NYSE:CRL, Diagnostics & Research, NYSE|0 Comments

Charles River Laboratories Upgraded to Buy on Jefferies

Trending News 🌥️ Charles River Laboratories ($NYSE:CRL) is a company that provides products and services to support the development and [...]

By GoodWhale|October 3, 2022|Categories: Diagnostics & Research|Tags: $NYSE:CRL, Diagnostics & Research, NYSE|0 Comments

Charles River Laboratories International, Inc. EPS Estimates for FY2023 Decreased by Zacks Research
Gallery

Charles River Laboratories International, Inc. EPS Estimates for FY2023 Decreased by Zacks Research

Trending News 🌥️ CRL Stock Intrinsic Value – Charles River Laboratories($NYSE:CRL) International, Inc. is a leading provider of drug discovery, [...]

By GoodWhale|September 23, 2022|Categories: Diagnostics & Research, Intrinsic Value, Profitability|Tags: $NYSE:CRL, Diagnostics & Research, NYSE|0 Comments

Charles River Laboratories expands cell therapy facility

Charles River Laboratories beats earnings estimates by $0.13 in Q3

Charles River Laboratories Upgraded to Buy on Jefferies

Charles River Laboratories International, Inc. EPS Estimates for FY2023 Decreased by Zacks Research

Investing Everyone Can Do.